Background And Objective: Knee arthroplasty is a major surgery with potential significant blood loss. Assess the efficacy and safety of topical administration of 3g of tranexamic acid (TXA) in terms of reducing blood loss in knee arthroplasty.
Material And Method: A randomized, phase III, double-blind, placebo-controlled clinical trial has been conducted.
Background And Objective: Knee arthroplasty is a major surgery with potential significant blood loss. Assess the efficacy and safety of topical administration of 3g of tranexamic acid (TXA) in terms of reducing blood loss in knee arthroplasty.
Material And Method: A randomized, phase III, double-blind, placebo-controlled clinical trial has been conducted.